Cardiex Ltd
ASX:CDX
Cardiex Ltd
Income from Continuing Operations
Cardiex Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cardiex Ltd
ASX:CDX
|
Income from Continuing Operations
-AU$9.4m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-34%
|
|
Neurotech International Ltd
ASX:NTI
|
Income from Continuing Operations
-AU$7.8m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Income from Continuing Operations
-AU$19.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-11%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Income from Continuing Operations
-AU$4.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-166%
|
CAGR 10-Years
7%
|
Cochlear Ltd
ASX:COH
|
Income from Continuing Operations
AU$350.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Income from Continuing Operations
-AU$3.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is Cardiex Ltd's Income from Continuing Operations?
Income from Continuing Operations
-9.4m
AUD
Based on the financial report for Dec 31, 2023, Cardiex Ltd's Income from Continuing Operations amounts to -9.4m AUD.
What is Cardiex Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-34%
Over the last year, the Income from Continuing Operations growth was 39%. The average annual Income from Continuing Operations growth rates for Cardiex Ltd have been -40% over the past three years , -24% over the past five years , and -34% over the past ten years .